Education
About Us
Working with TipRanks
Follow Us
Univec (UNVC)
OTHER OTC:UNVC
UNVC Stock Chart & Stats
$0.01
<$0.01(15.00%)
At close: 4:00 PM EST
$0.01
<$0.01(15.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume71.93K
Average Volume (3M)N/A
Market Cap
$6.56M
Enterprise Value$7.58M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.27M
Price to Earnings (P/E)―
Beta0.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,523,096,700
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)-0.32
Price to Sales (P/S)143.95
P/FCF Ratio-96.34
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue141.16
Enterprise Value/Gross Profit-2.04K
Enterprise Value/Ebitda-6.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UNVC FAQ
What was Univec’s price range in the past 12 months?
Currently, no data Available
What is Univec’s market cap?
Univec’s market cap is $6.56M.
When is Univec’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Univec’s earnings last quarter?
Currently, no data Available
Is Univec overvalued?
According to Wall Street analysts Univec’s price is currently Overvalued.
Does Univec pay dividends?
Univec does not currently pay dividends.
What is Univec’s EPS estimate?
Univec’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Univec have?
Univec has 2,523,096,700 shares outstanding.
What happened to Univec’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Univec?
Currently, no hedge funds are holding shares in UNVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Univec
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---